JP Morgan Healthcare Investor Conference 2020

The “go-to” and granddaddy of ALL healthcare conferences

by Gregg A. Masters, MPH

It’s about time to start thinking about the ‘Woodstock’ of healthcare investor focused innovation conferences to be held in San Francisco, California in January of 2020.

For more information and context on what to expect checkout JP Morgan’s “Insights & Implications from the J.P. Morgan Healthcare Conference”.

More will be posted here once the JP Morgan portal is published, which we expect to be in the October or November timeline. It’s often a slow build on completing and publishing the program schedule.

One of the characteristics unlike any other conference I attend during the year is this is not just the JP Morgan Healthcare Conference, it is literally a healthcare and life sciences innovation “love-fest” – that is if you believe “men in suits” (usually those wearing pinksocks, ie, the ‘real men wear pink types) are capable of letting go of their protective, risk averse due diligence tools and open up to the rich stream of informational insights afforded by our inner ‘knower‘ – the voice we occasionally hear but rarely listen to let alone or act upon.

One of the bigger and better attended events is the StartUp Health Festival which has become the gathering place for healthcare innovators and the ‘army of transformers‘ StartUp Health is fueling.

Some posts from last year’s conference:

#JPM19 Best Bets

37th JP Morgan Healthcare Investor Conference

Day One #JPM19

What I Didn’t See at @JPMorgan Healthcare Conference #JPM19

Finally, as a committed community steward, sharing for free and for fun via the social domain, we’ve again registered the ‘un-official#JPM20 hashtag with our friends as Symplur via the health hashtag project – the go-to registrar for healthcare related hashtags.

More shortly!


Validation Matters – Episode 1: RD Whitney CEO Validation Institute

by Gregg A. Masters, MPH

Health Innovation Media is pleased to announce the launch of the inaugural private labelled podcast series titled ‘Validation Matters‘.

Validation Matters is sponsored by Validation Institute, a membership organization dedicated to drive demand for high-value healthcare across the industry. Validation Institute (VI) is made up of a network of healthcare vendors, health benefits advisors, and purchaser benefit managers focused on delivering better health value and stronger outcomes than conventional healthcare. VI’s validation and certification programs ‘make it easier f or employers to find high-value health care solutions’.

In episode I of ‘Validation Matters“, RD WhitneyCEO of Validation Institute discusses the genesis of the company, and how VI works to enable healthcare purchasers to buy smart while enabling the triple aim.

Please consider subscribing to this podcast!


World Health Care Congress 2019

by Nick van Terheyden MD and Gregg Masters MPH

One ritual on the punch-list of many thought leaders (in both capital ‘P’ policy and operational theaters) and innovators in the healthcare transformational conversation is the work of Vidar Jorgenson, et al, producing and curating the World Health Care Congress annual gathering in our nation’s capital.

Health Innovation Media was on the ground with our #pinksocks pop-up studio in 2018. We live streamed our audio featuring top talent including former Chief Technology Officer of the United States under the Obama Administration and President, Care Journey Aneesh Chopra, then Assistant Medical Director and CMIO, Kaiser Permanente, Southern California John Mattison, MD and former Chief Innovation Officer and Executive Vice President of UPMC, now EVP and Chief Strategy Officer of Atrium Health Rasu Shrestha, MD, MBA.

Aneesh Chopra, President Care Journey

Audio from our live streaming of World Health Care Congress 2018 can be previewed on demand. Day one is here, and day two here.

This year our colleague Nick van Terheyden, MD aka ‘Dr. Nick‘, served up an agile version of our pop-studio and managed to tap top talent in the mix including: Craig Samitt, MD, MBA, President and CEO of Blue Cross Blue Shield, Minnesota, Martin Makary, MD, Professor of Surgery and Chief Islet Transplantation, Johns Hopkins Medicine, Robert Pearl, MD, former CEO of the Permanete Medical Group and author of ‘Mistreated: Why We Think We Are Getting Good Healthcare – And Why We’re Usually Wrong‘ and Former Secretary of the Veterans Administration, the honorable David Shulkin, MD.

I especially appreciate Dr. Samitt’s sober commentary on the apparent failure of industry wide innovation efforts to restrain the persistent appetite of our production driven healthcare economy, and it’s strain on the budgets of the American people including Federal, State and local governments. Dr. Samitt’s candor brings to mind a 2014 post on ACO Watch titled: ‘‘Eating Glass?’: A DaVita Healthcare Partners Hiccup or Impending Physician Integration Implosion?’ Take a look, in my biased opinion it’s worth the read.


The Population Health Colloquium: Social Determinants of Health, Precision Medicine and the Triple Aim

By Fred Goldstein, MS and Gregg Masters, MPH*

The field of population health continues to grow and create new areas of exploration and integration. Population health practitioners are called upon to play a central role as health systems, health plans or healthcare organizations work to implement their strategies designed to improve health care quality, access, outcomes and cost while weaning the US Healthcare system away from its fee-for-service reimbursement paradigm.

From the emerging recognition that Precision Medicine is not antithetical to population health, to the development of unique approaches to address the social determinants of health, it’s an exciting time.

This year’s agenda for the Population Health Colloquium reflects the dynamic nature of the field, featuring leading healthcare experts from academia, healthcare systems, health plans, data and analytics companies, population health companies, regulators, innovators and entrepreneurs. To add to the excitement, the $100,000 Hearst Health Prize will be awarded to one of three deserving finalists: the University of Arkansas Arkansas SAVES program; the Mental Health Outreach for Mothers (MOMS) Program; and the Sharp Transitions Program.

A range of value-based care and alternative payment models are being implemented across the U.S. healthcare landscape, and will be covered in depth at the Colloquium with presentations on ‘Are Alternative Payment Models Working?’ presented by Lawton R. Burns, PhD, MBA, Director of the Wharton Center for Healthcare Management and Economics and the James Joo-Jin Kim Professor of Health Care Management, Wharton School, University of Pennsylvania, and François de Brantes, MBA, Senior Vice President of Commercial Business Development, Remedy Partners. There will also be a number of ‘mini-summits‘ addressing value-based care and alternative payment models in different contexts and settings (orthopedic bundle, collaborative care, chronic conditions, patient engagement, and elder care).

The move to alternative sites of care will be covered in ‘Evolving Care Outside the Hospital to Meet Consumers Where They Are’, presented by Niki Buchanan, MA, PHM, General Manager, Philips PHM, and Shauna Coyne, Director of Innovations, New York-Presbyterian Hospital.

A Special Dinner Program (Tuesday, March 19), download brochure here.

Cells Are the New Cure: Advances in Precision Medicine‘ will focus on innovations, science, technology and medicine and explore the advances in precision medicine that are providing pathways to cures using human cells. The Panel will include, Richard M. Cohen Journalist, News Producer, “Dr. Max” Gomez, PhD, an Emmy-Award Winning Medical Correspondent, Robin L. Smith, MD, MBA, President and Chairman, Cura Foundation, and Meredith Vieira, Emmy Award-winning TV Journalist; Host, Executive Producer and Anchor.  Attendees at this event will each receive a copy of ‘Cells are the New Cure’ by Robin Smith, MD, MBA and “Dr. Max” Gomez, PhD and ‘Chasing Hope’ by Richard M. Cohen.

Join us on PopHealth Week, Wednesday, March 6th, as we chat with co-authors Max Gomez, PhD, and Robin L. Smith, MD, MBA to preview the principal message featured in their book including implications for population health management.

A major focus of the final day will be looking at the healthcare system itself, discussing what’s wrong and how we (including healthcare consumers) can fix it. Presentations will be given by Robert Pearl, MD, Contributor, Forbes; Professor, Stanford University School of Medicine, author of ‘Mistreated: Why We Think We’re Getting Good Health Care — and Why We’re Usually Wrong, Elisabeth Rosenthal, MD, Editor-in-Chief, Kaiser Health News, author of ‘An American Sickness: How Healthcare Became Big Business and How You Can Take It Back and Archelle Georgiou, MD, President, Georgiou Consulting; Author and Consumer Advocate, author of ‘Healthcare Choices: 5 Steps to Getting the Medical Care You Want and Need.

To conclude the Colloquium, the ever popular Health Leaders Panel will be moderated by Dr. Nash. This year’s line-up includes Mandy Mangat, MD, MPH, Chief Medical Officer, Navvis Healthcare; David Nace, MD, Chief Medical Officer, Innovaccer; Rita Numerof, PhD, President, Numerof & Associates, Inc.; and Gary A. Puckrein, PhD, President and Chief Executive Officer of the National Minority Quality Forum.

And that’s only a peek at some of the timely presentations, panels and mini-summits at this year’s Colloquium. If you haven’t registered yet, (more information here), there’s still time to block your schedule, secure your travel arrangements and come to the best Population Health Conference of the year,  March 18-20th at the Loews Philadelphia Hotel, in the City of Brotherly Love.

Still on the fence?, check out this invitation to the Colloquium via David B. Nash, MD, MBA, Dean, Jefferson College of Population Health, and our last chat with Dr. Nash, inAccelerating toward “Value Based Care”…or, “No Outcome, No Income”.’

We hope to see you there!


* Post sponsored by the Jefferson College of Population Health

@HIMSS 2019: @Accenture Global Health Practice Head @DrKavehSafavi Highights Consumer Health Survey Results

By Gregg A. Masters, MPH and Frederic S. Goldstein, MS

In what has become a HIMSS (Health Information Management Systems Society) tradition Health Innovation Media co-host Fred Goldstein sat with Kaveh Safavi, MD, MBA, Senior Managing Director and Head of Global Health Practice for Accenture to source the latest trends, developments and sentiment on the future of healthcare from the ‘consumer‘ point of view.

The growing impact of technology to empower and democratize healthcare can not be denied. This is both a warning and an opportunity for legacy healthcare operators to retool their business models, footprints, culture and the strategic positioning of assets (both virtual and ‘brick and sticks’) to serve an increasingly motivated, and to a certain extent dis-satisfied healthcare consumer.

Bottom line? Active participation, pricing transparency and shared decision making – beyond mere ad copy – is no longer an option. Watch this space!

Noteworthy interview points include:

½ of respondents in US use non-traditional healthcare services and ¼ use digital nontraditional means to access healthcare

Rapid growth in people wanting to use a digital channel as an alternative to the current healthcare system

Sentiment shift driven by what’s been happening outside healthcare

Dis-satisfaction with the healthcare system from the younger generation – access and location, will probably not change as they age…

Artificial Intelligence (AI) presents a means to generate efficiencies in the system, see AI And Healthcare: A Giant Opportunity

In this interview Dr. Safavi highlights key findings of Accenture’s 2019 Digital Health Consumer Survey.

The report’s executive summary notes:

Healthcare consumers today are changing, and their expectations for convenience, affordability and quality are redefining how they engage at each stage of care.

Younger consumers are not satisfied with healthcare’s status quo and consumers of all generations are more willing to try non-traditional services.

Non-traditional healthcare, such as virtual care and retail walk-in clinics, is gaining in popularity and use.

There is lots to digest in Accenture’s latest consumer sentiment survey. Be sure to check out the video interview, download the survey and read the Forbes piece which validates much of Dr. Safavi’s narrative.


Finally! @ONC_HealthIT & @CMSgov ‘Drop’ Interoperability & Empowerment Regs #NPRM

Bt Gregg A. Masters, MPH & Fred Goldstein, MS

At the @HIMSS pre-conference NHIT Summit this morning, the National Coordinator for HealthIT Donald Rucker, MD, (follow via @donrucker) broke news at the Health Information Management Systems Society (HIMSS) in Orlando, Florida.

While the community expected the Notice of Proposed Rule Making (NPRM) ‘might drop during HIMSS, Fred and I were happy to witness and document this long expected regulatory proposal.

Later in the morning Peter Ashkenaz, Director of Media Affairs at Office of the National Coordinator for Health Information Technology (ONC), released the following fact sheet‘.

Enjoy the raw footage!


LIVE From HIMSS 2019

LIVE From Nuance Communications booth #3345
Tuesday, February 12th 11AM – 1PM Eastern
Wednesday, February 13th 1PM – 3PM Eastern

Health Innovation Media courtesy of Nuance Communications will host and live stream four (4) hours of internet radio broadcasting on Tuesday and Wednesday, February 12th and 13th 2019.

This year we are simulcasting the LIVE From HIMSS pinksocks pop-up studio broadcast with our syndication partner HealthCareNOW Radio. A big s/o to the divas’ of healthcare, healthtech and health innovation internet radio broadcasting Roberta Mullin and Carol Flagg

The complete program guest schedule is posted here.

Tune in!

Accelerating toward “Value Based Care”…or, “No Outcome, No Income”

By Gregg Masters, MPH and Fred Goldstein, MS

The concept of ‘managed healthcare’ has been part of the health policy lexicon in one way or another for decades, and has been variably embraced and scorned by different stakeholders.  Now that costs have reached unsustainable highs and life expectancy for Americans is on the decline, we’ve finally begun exploring ways to move from a ‘sick care model’ to one that values the health of the individual and the community.

Individuals point to the legacy U.S. fee-for-service payment model as either the inflationary culprit of a cost prohibitive, often inaccessible healthcare delivery system with wide variations in both quality and outcomes, or conversely, as the ‘strong medicine’ our challenged ‘health system’ requires. U.S. healthcare per capita spending is at a 2-5x that of its international peers (developed nations in the OECD) since it’s fueled by a set of incentives that encourage healthcare providers to ‘do more, to earn more’.

Our industry remains challenged to transform its care delivery model to enable the system to consistently deliver high quality care at reasonable price points both the end user (patient or consumer) or third party payer deem to be ‘fair value’ or reasonable.

Robust conversations in board rooms of major healthcare organizations have focused on the impact of the social determinants of health – non-clinical concerns (food and housing insecurity, poverty, education and employment) – on health status, have leaders beginning to direct their focus outward in an effort to understand how health care delivery must change to meet these critical needs. 

It’s generally acknowledged that when payment is ‘episodic’ in nature (fee-for-services) we incentivize a sick care model that merely treats symptoms without impacting overall health. When we examine health from a population-level perspective, we are able to address health maintenance or promotion at the individual or community level, by putting a spotlight on the causes of the underlying presenting ‘dis-ease’.

Both Government and the private sector are actively looking to transfer risk via a range of payment models from capitation to bundles, to all-inclusive population-based payments. However, their uptake has been slow, spotty and has met with variable degrees of success. Yet, all are organically converging under a ‘population health’ perspective or frame of mind.

Conceptually, a ‘population health’ approach makes enormous sense.  Because it typically involves connecting with stakeholders and organizations outside the healthcare delivery system, successful implementation often presents with significant challenges. The ‘how to’ is often disguised in myriad choices not easy to discern, differentially evaluate, and fund.

By all appearances, the move away from fee-for-service medicine to value based healthcare is accelerating.  Underlying this change is the not insignificant question of how one successfully completes the transition to the new paradigm while maintaining care quality and financial margins.

Some have downplayed the impact of population health…or positioned it in opposition to another high priority theme for healthcare leaders, i.e., precision medicine.  Yet, it is, in fact, the framework for success. Understanding the specific characteristics of the target population is the open window into the risk, outcomes and costs associated with the group, and the best way to truly measure one’s impact over time. Did the health of the group of persons we served improve overall?

There is good news for those who view precision medicine and targeting individuals as the ideal approach; in fact, the two actually can co-exist. Assessment and stratification, resulting in an intervention(s) to the individual are key characteristics of both precision medicine and population health frameworks. The introduction of genomics, proteomics and other more “individualized” assessment measures allows for a more precise determination of risk, stratification and selection of the appropriate intervention(s). 

None of this is easy, but it is necessary if we are to improve the health of our nation’s citizens in a financially responsible way. Social determinants of health play an oversized role in health status, and in order to address them effectively, we must undertake new approaches and thinking, working in broader coalitions and collaborative community partnerships.

Enter the Population Health Colloquium

Jefferson College of Population Health opened a decade ago, under the direction and guidance of its Founding Dean, David B. Nash, MD, MBA, as the first institution dedicated to the study of population health. Since 2008, it has been adding value via research, empirically demonstrated best practices and stewarding the training of the practitioners equipped to connect health with healthcare delivery.

In its 19th iteration, the Colloquium is an immersive experience that brings together thought leaders, innovators and entrepreneurs across the care continuum, including health policy wonks and regulators, to network and learn from one another.

Dr. Nash extends his invitation to the community in the video below:

This Wednesday, February 6th at on PopHealth Week, Dr. Nash chats with Niki Buchanan, Population Health Management Lead at Philips Wellcentive.

For more information on the 19th Population Health Colloquium including keynote faculty and the program agenda, including the Hearst Health Prize, click here.

See you in Philly!

LIVE From @HIMSS 2019 #HIMSS19

by Gregg A. Masters, MPH & Nick van Terheyden MD

Ten plus years in to what some consider ‘top down’ (vs. ‘bottoms up’) artificial stimulation by HITECH/ARRA of a vendor/supplier ecosystem offering a range of ‘not ready for prime time‘ electronic health or medical records, we’re still searching for remedies to chronic user concerns and well documented interoperability issues, see: ‘Electronic Health Record (EHR) Safety and Usability. See What We Mean‘ published by Medstar Health National Center for Human Factors in Healthcare.

Our ‘pluralistic‘ American healthcare ‘non’-system is unique on a number of levels not the least of which is the 2-4x spend multiple when contrasted to other developed nations reporting to the Organization for Economic Cooperation and Development (OECD).

Yet, the U.S. historically driven by it’s once ‘good ole yankee ingenuity’ (now increasingly of the imported/immigrant driven variety) has deep roots and legitimate claims to the title of the center of gravity of the innovation impulse.

To many, ‘American Exceptional-ism‘ means we can reliably innovate ourselves out of just about any social, economic or other national dilemma from climate change to fulfilling the promise of the triple aim (better experience of care, improved outcomes at lower per capita costs).

Enter The Voice Play: Will Voice Dominate HIMSS?

From desktops to keywords to now voice commands to remote or networked devices, smart phones or tethered i-Watches whether ingested by machine driven deep learning algorithms developed by Apple for SIRI, or ‘Ok Google’ for search or even the growing home or office ‘Alexa’ commands intent to make our lives easier, we’re well into the ‘IoT’ era where voice may just be the enabling equivalent of ‘digital capital’.

Health Innovation Media has been following and reporting from HIMSS since 2010. In 2013 we launched the first guerrilla new media operation wirelessly streaming live content from the Exhibit Hall to one-on-one interviews with top talent from our ‘pop-up studio‘, see: ‘5 Days in March: A Tale of Independent Media Passion, Determination and Agility‘.

This year thanks to Nuance, the leader in ‘conversational AI‘ for health, this will be our fourth year in row co-locating our pop-up studio on the floor in the HIMSS Exhibition Hall.

LIVE From HIMSS 2019

We’re broadcasting ‘LIVE From @HIMSS 2019‘ two hours per day, beginning Tuesday, February 12th from 11AM – 1PM and Wednesday, February 13th, from 1PM – 3PM. All times are Eastern.

The schedule of include:

Our studio will be hosted in the Nuance Communications booth #3345. The area floor plan is pasted below:

HIMSS Exhibition Floor Plan

Context for Nuance’s pivot to an ‘all in on conversational AI‘ in health can be found in recent presentation by Mark Benjamin, CEO to the JP Morgan Healthcare Conference (NOTE: this link has time limited access and though free, registration may be required) in San Francisco and likely to be affirmed with management’s discussion of operating results during Nuance’s Q1 2019 results conference call, February 7th, 2019 5:00 PM ET, register here.

Meanwhile, Nuance announced their partnership with MEDITECH focusing on new AI-Powered Virtual Assistants for Healthcare building on years of experience to integrate their new virtual assistant into the clinician workflow to facilitate the clinicians patient interaction removing the data access drudgery and freeing the clinicians to focus on the patient.

Additionally, Nuance has issued the following:

First Quarter 2019 Results

Nuance Brings Virtual Assistant Technology to 300,000 Dragon Medical One Cloud Users

On LIVE From HIMSS 2019 we’ll be discussing these innovations and their application at the clinical work face with clinicians, users, experts and patients exploring the new world using voice to demystify technology and easing the learning and technical challenges long associated with electronic health records.

So will voice be the game changer in healthcare that brings the vision of the triple aim one step closer to the industry’s collective grasp? We think a pretty strong argument can be made here.


Share Your PT Innovation @APTA CSM 2019 #APTACSM

by Gregg A. Masters, MPH

Those of us healthcare ‘insiders‘ generally grasp the notion that the cost burden of access to widely variant, discontinuous and for the most part ‘silo-ed’ healthcare services in the U.S. is an outlier when compared to other developed (OECD) economies (see chart below).

This persistent relationship accompanied by epidemic levels of physician and clinician burnout if not outright demoralization has caused the question of ‘value‘ to resurface as the strategic imperative of our time. Thus, so called ‘value based‘ healthcare vs. it’s legacy (and persistent) fee-for-services incentive momentum is now the new, new thing in healthcare. The value agenda is front and center in healthcare delivery, quality and outcomes innovation, with ‘Zeigeist’ level disruption expected for ecosystem stakeholders including hospitals, health systems, physicians, medical groups, ancillary services providers, pharma, medical devices, digital health apps or platforms, or in other words the entire supplier value chain.

Thus much of the ‘innovation energy‘ in the $3.3 trillion U.S. healthcare economy inclusive of primary, specialty and sub-specialty services to devices, pharma, platforms, digital health apps and an ever expanding practice portfolio of complementary or functional medicine alternatives seem to emerge almost daily.

After decades of relentless and occasional obscene premium increases, accompanied by cost shifts from third party payors, managed health plans, or legacy insurance underwriters to its members or covered beneficiaries through reduced coverage, service caps, higher deductibles and co-pays, the core industry challenge persists, i.e., the ‘triple aim‘, better care, better outcomes at lower per capita cost remains just outside of our collective reach.

The CDC estimates that 90% of the U.S. healthcare spend is attributable to the burden of chronic disease, including heart disease, stroke, cancer and diabetes at the top of the class. It can be safely assumed that members and participants in American Physical Therapy Association (APTA) Combined Sections Meeting in Washington, D.C. from January 23 – 26th will feature keynote talks, and sessions directly or indirectly devoted to achieving the triple aim. For more information on APTA CSM, see: CSM 2019: Connect.Learn.ChooseDC.

Share Your Physical Therapy Innovation

If you have a story that drove your passion to innovate – from clinical workflow efficiencies, to platform, app, AI or device assisted outcomes improvement, come share your story.

To schedule, please ping interest via twitter via @2healthguru with some background information and your value proposition. We’ll set-up in booth #2111.

Health Innovation Media is co-locating it’s signature #pinksocks ‘pop-up‘ studio on site with the brilliant, serial entrepreneur and ‘skin in the game‘ founder and CEO of 9zest (follow via @9zest_inc), Manoj Agarwala.

As an epilepsy survivor, Manoj launched 9zest as:

an Intelligent Digital Health Rehab Platform with modules specially designed for Stroke, Parkinson’s, Chronic Pain and Physical Therapy.  9zest is a white label solution for rehab and physical therapy leaders.

We caught up with Manoj at the World Health Care Congress in Washington, D.C. last May. My colleague and Health Innovation Media co-host Douglas Goldstein got the details and company history.

Get to know Manoj, the 9zest value proposition and what inspired him to make a difference in the lives of others.

Join us!

Add value or forget about it!